Directory 2



1. MDM of halo nevus-like type; VI10-1ab

2 Regressing halo nevus-like melanoma; VI10-1

3. Genital nevi, atypical genital nevi, and melanomas; VI10-2

4. Spindle cell nevi and melanomas; VI10-3

5. Spitz variants; VI10-4

6. Spitz category, nosology; VI10-5

7. MDM of Spitz nevus-like type; VI10-6ab

8. Pigmented spindle cell nevi (Reed); VI10-6

Chapter 11

9. Atypical pigmented spindle cell; VI11-1ab

10. Combined nevus; VI11-1

11. Deep penetrating nevus; VI11-2

12. Blue nevi; VI11-3

13. Deep mesenchymal melanocytic hamartoma; VI11-4

 Chapter 12

14. Nevoid melanoma, a different perspective; VI12-1

15. Variant malignant melanoma, a third perspective;VI12 -2

16. A classification of melanoma; VI12 -3

17. Fascicular melanomas, not of the type; VI12-4

18. Uncommon variants of melanoma; VI12-5

Chapter 13

19. Manipulation of virtual images; VI13-1

20. Acidophilic body; VI13-2

21. Anaplasia; VI13-3

22. Ancient change; VI13-4

23. Angiogenesis;VI13-5

24. Atypical hyperplasia; VI13-6

25. Controversies; VI13-7

26. de novo melanoma; VI13-8

27. Dysplasia; VI13-9

28. Ecological niche, continuity of patterns; VI13-10

29. Fibroplasia; VI13-11

Chapter 14

30. Growth factors; VI14-1

31. Indeterminate melanocytic dysplasia; VI14-2

32. Interobserver concensus; VI14-3

33. Malignancy; VI14-4

Chapter 15

34. Malpractice; VI15-1

35. Maturation; VI15-2

36. Neoplastic continuum, arbitrary segmentations; VI15-3

37. Melanoma category; VI15-4

38. Melanocytic neoplasia of indeterminate malignant potential; VI15-5

39. Uncertainness of malignant potential; VI15-6

40. Microstages of neoplasia and virtual images; VI15-7

41. Neoplastic economies; VI15-8

42. Appositional fibroplasia; VI15-9

43. Neurocutaneous melanosis syndrome; VI15-10

44. Neurocristic hamartoma; VI15-11

45. Falsification of real images; VI15-12

46. Patterns of aggregation; VI15-13

Chapter 16

47. Criteria for diagnosis of SSM; VI16-1

48. Primary configuration; VI16-2

49. Prognostic categories; VI16-3

50. Radial growth; VI16-4

51. Conflicts - real images with observed clinical behavior; VI16-5

52. Segmentation of neoplastic continua; VI16-6

53. Signet ring cell; VI16-7

54. Small round cell; VI16-8

55. Spindle cell; VI16-9

56. Statistics; VI16-10

57. Technology and the art of pathology; VI16-11

58. Technical artifacts - real and virtual images; VI16-12

59. Therapeutic commonness in the category of borderline neoplasia; VI16-13

60. Thickness, labels, and prognostications; VI16-14

61. Thin melanoma arising in atypical nevus;VI16-15

Chapter 17

62. Borderline melanocytic neoplasia of indeterminate malignant potential; VI17-1

63. Tolerance for conflicting reports; VI17-2

64. Variants of melanoma; VI17-3

65. Vertical growth; VI17-4

66. Virtual images; VI17-5

67. Utility of real and virtual images; VI17-6

68. Testimony of experts; VI17-7

69. Virtual images - factual or fanciful; VI17-8

70. In transit metastases; VI17-9

71. Final comments; VI17-10

72. Intellect & emotions; VI17-11



VA3T2&3Direct2P1D8: Relationships are as described for VA1 & 2. This is a portion of the site diagram, including the third portion of tier 2 (Direct2), and the daughter chapters of Directory 2 chapter. Navigation is as previously described.

Next Page                         Back a Page

Up to Parent Page              Down to first Child Page

The Whithers are available on:    Virtual Images